Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022			1,026,097
Beginning balance at Dec. 31, 2022	$ 61,753			$ 279,733	$ (217,736)	$ (244)
Stock-based compensation expense	5,427			5,427
Issuance of common stock; net of issuance costs (in shares)			58,412
Issuance of common stock; net of issuance costs	2,876			2,876
Other comprehensive loss, net	624					624
Net Income (Loss)	$ (38,349)				(38,349)
Ending balance (in shares) at Dec. 31, 2023	0
Ending balance at Dec. 31, 2023
Ending balance (in shares) at Dec. 31, 2023			1,084,509
Ending balance at Dec. 31, 2023	32,331			288,036	(256,085)	380
Beginning balance
Stock-based compensation expense	3,239			3,239
Issuance of common stock in connection with vesting of restricted stock units, (in shares)			6,828
Issuance of common stock in connection with vesting of restricted stock units	93			93
Issuance of stock in connection with an Asset Purchase Agreement (in shares)		161	62,594
Issuance of stock in connection with an Asset Purchase Agreement	1,890	$ 1,360		530
Round-up shares from the 1-for-25 reverse split effective August 29, 2024 (in shares)			163,058
Other comprehensive loss, net	(283)					(283)
Net Income (Loss)	$ (21,439)				(21,439)
Ending balance (in shares) at Dec. 31, 2024	161	161
Ending balance at Dec. 31, 2024	$ 1,360
Ending balance (in shares) at Dec. 31, 2024			1,316,989
Ending balance at Dec. 31, 2024	15,831	$ 1,360		$ 291,898	$ (277,524)	$ 97
Beginning balance	$ 1,360